Biotech
RENO, NV: Lifeline Biotechnologies Recaps 2015 Activity and Forecasts 2016 Expectations ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 12/22/15 -- Hemostemix Inc. ("Hemostemix" or the "Company") (TSX VENTURE: HEM), a clinical-stage autologous cell-therapy company, announced to ...
LYON, FRANCE: LYON, FRANCE -- (Marketwired) -- 12/22/15 -- Flamel Technologies (NASDAQ: FLML) today announced positive interim results from a Phase 1a clinical trial in healthy volunteers of a once weekly subcutan ...
BUFFALO, NY: BUFFALO, NY -- (Marketwired) -- 12/22/15 -- (NASDAQ: CBLI) today announced that through a series of transactions and in cooperation with Open Joint Stock Company RUSNANO (Rusnano) it has recapitaliz ...
SYDNEY, AUSTRALIA: SYDNEY, AUSTRALIA -- (Marketwired) -- 12/22/15 -- Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD)Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD), a leading immuno-oncology company, is pleased to announce the i ...
ATLANTA, GA and DAVIE, FL: ATLANTA, GA and DAVIE, FL -- (Marketwired) -- 12/21/15 -- Trunity Holdings, Inc. (OTCQB: TNTY) (the "Company") today announced an update on its planned restructuring to include the conversi ...
GENEVA, SWITZERLAND: GENEVA, SWITZERLAND -- (Marketwired) -- 12/21/15 -- The Board of Directors at its meeting of December 16, 2015 appointed Ed Holdener as Chief Executive Officer of the Company, effective immediately.T ...
SAN FRANCISCO, CA: SAN FRANCISCO, CA -- (Marketwired) -- 12/21/15 -- Medivation, Inc. (NASDAQ: MDVN) today announced the initiation of an international Phase 2 clinical trial that will evaluate the safety and efficacy ...
LONDON, ONTARIO: Distinguished European Consortium Awarded Approximately $8.5 Million CAD by the European Commission via Its Horizon 2020 Program to Partner Advanced Cell Based Factor VIII Therapy in Collaboration Wit ...
MELBOURNE, AUSTRALIA: MELBOURNE, AUSTRALIA -- (Marketwired) -- 12/21/15 -- Molecular diagnostics company Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) ("Company") announced today the publication of a ne ...
SOUTH SAN FRANCISCO, CA: Threshold to Focus on Clinical Trials of Tarloxotinib While Evaluating Potential Further Development of Evofosfamide and Other Strategic Options for the Company ...
SAN FRANCISCO, CA: SAN FRANCISCO, CA -- (Marketwired) -- 12/18/15 -- announced today that it has updated coverage on Soligenix, Inc. ("The Company" or "SNGX") (OTCBB: SNGX), a clinical stage biopha ...
ATLANTA, GA: ATLANTA, GA -- (Marketwired) -- 12/17/15 -- Trunity Holdings, Inc. (OTCBB: TNTY) (OTCQB: TNTY) made further announcements regarding its restructuring plan today, including its plans to change the nam ...
SEATTLE, WA: Atossa Retains 19% Ownership Through Preferred Stock ...
EXTON, PA: EXTON, PA -- (Marketwired) -- 12/17/15 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors has approved a first-quarter 2016 dividend of $0.12 ...
MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 12/17/15 -- IBEX Technologies Inc. ("IBEX" or the "Company") (TSX VENTURE: IBT) today reported its financial results for the quarter ended Oc ...
VANCOUVER, BRITISH COLUMBIA: Phase 1 clinical trial investigating the use of a patient-specific cell-based dermal rejuvenation product (RCS-01) is scheduled to deliver data in late 2016 ...
HALIFAX, NOVA SCOTIA: HALIFAX, NOVA SCOTIA -- (Marketwired) -- 12/17/15 -- Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX: IMV)(OTCQX: IMMVF), a clinical stage vaccine and immunotherapy com ...
LAS VEGAS, NEVADA: LAS VEGAS, NEVADA -- (Marketwired) -- 12/16/15 -- Online Disruptive Technologies, Inc. (OTC PINK: ONDR) (the "Company") is pleased to announce that its majority owned Israeli subsidiary, S ...
